Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Sexuality 1Sexual Dysfunction, Physiological 1Prostatic Neoplasms 1Postoperative Complications 1Neurologic Manifestations 1Infertility 1Glioma 1Glioblastoma 1Erectile Dysfunction 1Brain Neoplasms 1

Interventions

Gemcitabine 83Cisplatin 59pembrolizumab 28Paclitaxel 21Nivolumab 21Carboplatin 21Cystectomy 20Docetaxel 18durvalumab 17atezolizumab 17Magnetic Resonance Spectroscopy 16Specimen Handling 15Radiotherapy 14avelumab 13Mitomycin 13Sunitinib 12Doxorubicin 12Methotrexate 11Fluorouracil 11Vinblastine 10Filgrastim 7BCG Vaccine 7Sorafenib 6Ipilimumab 6Immunoglobulin G 6Disulfides 6Biopsy 6enfortumab vedotin 5cabozantinib 5Trastuzumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Urinary Bladder Neoplasms × Sildenafil Citrate × Clear all
NCT02422277 2015-05-06

Role of Low-intensity Shock Wave Therapy in Penile Rehabilitation Post Nerve Sparing Radical Cysto-prostatectomy

Mansoura University

Phase 2 Unknown
60 enrolled
Genitourinary

Urinary Bladder Neoplasms, Erectile Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡